Laurie L. Carr

1.1k total citations
15 papers, 810 citations indexed

About

Laurie L. Carr is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Laurie L. Carr has authored 15 papers receiving a total of 810 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 4 papers in Surgery. Recurrent topics in Laurie L. Carr's work include Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Laurie L. Carr is often cited by papers focused on Lung Cancer Diagnosis and Treatment (5 papers), Lung Cancer Research Studies (5 papers) and Lung Cancer Treatments and Mutations (5 papers). Laurie L. Carr collaborates with scholars based in United States, South Korea and Japan. Laurie L. Carr's co-authors include Julie E. Bauman, Renato Martins, Keith D. Eaton, David A. Mankoff, Peter Capell, Bernardo Goulart, Gary A. Koretzky, Kevin Latinis, Steven Eliason and Erik Peterson and has published in prestigious journals such as The Journal of Immunology, American Journal of Respiratory and Critical Care Medicine and Clinical Cancer Research.

In The Last Decade

Laurie L. Carr

15 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurie L. Carr United States 12 291 271 244 186 113 15 810
Ronald A. Ghossein United States 6 686 2.4× 288 1.1× 130 0.5× 267 1.4× 91 0.8× 8 1.0k
Ran Xie United States 12 168 0.6× 221 0.8× 185 0.8× 295 1.6× 37 0.3× 32 676
Yulia Bronstein United States 10 140 0.5× 644 2.4× 148 0.6× 209 1.1× 144 1.3× 15 903
Heather M. Shaw United Kingdom 13 166 0.6× 352 1.3× 132 0.5× 349 1.9× 60 0.5× 34 725
Jiachao Liang United States 7 554 1.9× 294 1.1× 112 0.5× 134 0.7× 94 0.8× 12 790
Todd Riehl United States 13 196 0.7× 431 1.6× 284 1.2× 288 1.5× 56 0.5× 28 831
Haizhen Lu China 13 74 0.3× 231 0.9× 145 0.6× 264 1.4× 99 0.9× 47 687
Carmela Iglesias Spain 10 128 0.4× 163 0.6× 108 0.4× 289 1.6× 262 2.3× 38 840
Elaina Cajulis United States 11 135 0.5× 301 1.1× 224 0.9× 432 2.3× 37 0.3× 23 838
Maria Gule-Monroe United States 12 544 1.9× 374 1.4× 183 0.8× 137 0.7× 58 0.5× 43 837

Countries citing papers authored by Laurie L. Carr

Since Specialization
Citations

This map shows the geographic impact of Laurie L. Carr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurie L. Carr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurie L. Carr more than expected).

Fields of papers citing papers by Laurie L. Carr

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurie L. Carr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurie L. Carr. The network helps show where Laurie L. Carr may publish in the future.

Co-authorship network of co-authors of Laurie L. Carr

This figure shows the co-authorship network connecting the top 25 collaborators of Laurie L. Carr. A scholar is included among the top collaborators of Laurie L. Carr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurie L. Carr. Laurie L. Carr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Carr, Laurie L., Debra S. Dyer, Pearlanne Zelarney, & Elizabeth Kern. (2022). Improvement in Stage of Lung Cancer Diagnosis With Incidental Pulmonary Nodules Followed With a Patient Tracking System and Computerized Registry. JTO Clinical and Research Reports. 3(3). 100297–100297. 5 indexed citations
2.
Dyer, Debra S., Pearlanne Zelarney, Laurie L. Carr, & Elizabeth Kern. (2021). Improvement in Follow-up Imaging With a Patient Tracking System and Computerized Registry for Lung Nodule Management. Journal of the American College of Radiology. 18(7). 937–946. 20 indexed citations
3.
Uthoff, Johanna, Matthew J. Stephens, John D. Newell, et al.. (2019). Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT. Medical Physics. 46(7). 3207–3216. 65 indexed citations
4.
Carr, Laurie L., Sean Jacobson, David A. Lynch, et al.. (2018). Features of COPD as Predictors of Lung Cancer. CHEST Journal. 153(6). 1326–1335. 58 indexed citations
5.
Carr, Laurie L., Jeffrey A. Kern, & Gail Deutsch. (2016). Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia and Neuroendocrine Hyperplasia of Infancy. Clinics in Chest Medicine. 37(3). 579–587. 16 indexed citations
6.
7.
Carr, Laurie L., et al.. (2016). Development of a Cancer Care Summary Through the Electronic Health Record. Journal of Oncology Practice. 12(2). e231–e240. 4 indexed citations
8.
Carr, Laurie L., Jonathan H. Chung, Rosane Duarte Achcar, et al.. (2014). The Clinical Course of Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia. CHEST Journal. 147(2). 415–422. 53 indexed citations
9.
Jett, James R. & Laurie L. Carr. (2013). Targeted Therapy for Non–Small Cell Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 188(8). 907–912. 22 indexed citations
10.
Bauman, Julie E., Keith D. Eaton, Laurie L. Carr, et al.. (2012). A Phase II study of pulse dose imatinib mesylate and weekly paclitaxel in patients aged 70 and over with advanced non-small cell lung cancer. BMC Cancer. 12(1). 449–449. 25 indexed citations
11.
Carr, Laurie L., James H. Finigan, & Jeffrey A. Kern. (2011). Evaluation and Treatment of Patients with Non–Small Cell Lung Cancer. Medical Clinics of North America. 95(6). 1041–1054. 23 indexed citations
12.
Carr, Laurie L., David A. Mankoff, Bernardo Goulart, et al.. (2010). Phase II Study of Daily Sunitinib in FDG-PET–Positive, Iodine-Refractory Differentiated Thyroid Cancer and Metastatic Medullary Carcinoma of the Thyroid with Functional Imaging Correlation. Clinical Cancer Research. 16(21). 5260–5268. 324 indexed citations
13.
Carr, Laurie L. & Daniel E. Gottschling. (2007). Does age influence loss of heterozygosity?. Experimental Gerontology. 43(3). 123–129. 15 indexed citations
14.
Latinis, Kevin, Laurie L. Carr, Erik Peterson, et al.. (1997). Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events. The Journal of Immunology. 158(10). 4602–4611. 152 indexed citations
15.
Sunden, Sara L.F., Laurie L. Carr, James L. Clements, David G. Motto, & Gary A. Koretzky. (1996). Polymorphism in and Localization of the Gene LCP2 (SLP-76) to Chromosome 5q33.1–qter. Genomics. 35(1). 269–270. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026